INVO Fertility (IVF) vs Nexalin Technology (NXL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
INVO Fertility is the larger company by market cap ($3.3 million vs $3.0 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IVF | NXL |
|---|---|---|
| Share price | $0.7275 | $3.63 |
| Market cap | $3.35M | $3.01M |
| 1-day change | -2.28% | -11.68% |
| P/E ratio (TTM) | 0.01 | — |
| EPS (TTM) | $127.95 | $-14.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $84.40 | $50.70 |
| 52-week low | $0.71 | $3.50 |
| Distance from 52-week high | -99.14% | -92.84% |
| Analyst consensus | none | buy |
| Avg. price target upside | +2649.14% | +313.22% |
| Average volume | 2.16M | 1.02M |
| Shares outstanding | 4.60M | 829.40K |
| Employees | 40 | 8 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About INVO Fertility
IVF stock →INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services and INVOcell Device segments.
Health Care · Medical/Dental Instruments · 40 employees
About Nexalin Technology
NXL stock →Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 8 employees
IVF vs NXL FAQ
Which is bigger, INVO Fertility or Nexalin Technology?
INVO Fertility (IVF) is larger, with a market capitalization of $3.35M compared with $3.01M for Nexalin Technology (NXL).
Are INVO Fertility and Nexalin Technology in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for INVO Fertility and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Nexalin Technology.